Metraipolis › archive › dc_2bd2a5bc3e7a

Emerging Nanomedicine Strategies for Chronic Disease Management Based on Chitosan — Europe PMC PMID:41683809

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41683809
DOI
10.3390/ijms27031387
License (as archived)
solo-consultazione
Archived
2026-11-06T09:57:10.244Z
SHA-256 of the archived text
924af62269e69a4f7b718c0a568be73906a525bde6418e7c547d1579b4afb5da
Stable URL of this page
https://metraipolis.com/documento/dc_2bd2a5bc3e7a

How to cite

Emerging Nanomedicine Strategies for Chronic Disease Management Based on Chitosan — Europe PMC PMID:41683809 — Europe PMC (en), https://europepmc.org/article/MED/41683809 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_2bd2a5bc3e7a (Metraipolis archive dc_2bd2a5bc3e7a, sha256 924af62269e69a4f7b718c0a568be73906a525bde6418e7c547d1579b4afb5da)
BibTeX
@misc{dc2bd2a5bc3e7a,
  title = {Emerging Nanomedicine Strategies for Chronic Disease Management Based on Chitosan — Europe PMC PMID:41683809},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41683809},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_2bd2a5bc3e7a; sha256 924af62269e69a4f7b718c0a568be73906a525bde6418e7c547d1579b4afb5da},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41683809. Agents can read the archived copy with the MCP tool read_document.